These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21476914)

  • 1. Inflammation in nonalcoholic steatohepatitis.
    Harmon RC; Tiniakos DG; Argo CK
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):189-200. PubMed ID: 21476914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Miele L; Forgione A; Gasbarrini G; Grieco A
    Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic steatohepatitis and the metabolic syndrome.
    Jiang J; Torok N
    Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis.
    van der Poorten D; George J
    Clin Liver Dis; 2008 Nov; 12(4):805-24, ix. PubMed ID: 18984468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology, pathogenesis and histopathology of fatty liver disease.
    Levene AP; Goldin RD
    Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of nonalcoholic steatohepatitis (NASH).
    Ma X; Li Z
    Chin J Dig Dis; 2006; 7(1):7-11. PubMed ID: 16412031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nonalcoholic steatohepatitis--a "new" hepatic disease].
    Grønbaek H; Eivindson MV; Hamilton-Dutoit S; Vilstrup H
    Ugeskr Laeger; 2003 Mar; 165(11):1115-8. PubMed ID: 12677985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L; Forgione A; Hernandez AP; Gabrieli ML; Vero V; Di Rocco P; Greco AV; Gasbarrini G; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):273-7. PubMed ID: 16231589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty liver: role of inflammation and fatty acid nutrition.
    Byrne CD
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):265-71. PubMed ID: 20189787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.
    Gambino R; Musso G; Cassader M
    Antioxid Redox Signal; 2011 Sep; 15(5):1325-65. PubMed ID: 20969475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease.
    Krawczyk M; Bonfrate L; Portincasa P
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):695-708. PubMed ID: 20955971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
    Larter CZ; Chitturi S; Heydet D; Farrell GC
    J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease.
    Daly AK; Ballestri S; Carulli L; Loria P; Day CP
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):253-63. PubMed ID: 21476920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis?
    Pattullo V; Douglas MW; George J
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):265-77. PubMed ID: 21476921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrogenesis in nonalcoholic steatohepatitis.
    De Minicis S; Svegliati-Baroni G
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):179-87. PubMed ID: 21476913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.
    Rolo AP; Teodoro JS; Palmeira CM
    Free Radic Biol Med; 2012 Jan; 52(1):59-69. PubMed ID: 22064361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2002; 2(1):11-9. PubMed ID: 12122975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.